Interview with Dr. Tyna Moore, ND, DC — What Women Need to Know About GLP-1 Microdosing, Peptides, Gut Health, and Hormonal Optimization

Table of Contents

• Why this conversation matters
• Guest snapshot
• Peptides 101
• Safe, practical peptide picks
• Regulatory and safety landscape
• NAD, exosomes, and their place
• GLP‑1 medications and microdosing
• Practical care pathways
• Gut health as the foundation
• Hormone replacement therapy (HRT) for midlife women
• Exercise, resistance training, and practical tools
• Supplements and small wins
• Finding a clinician: what to look for
• Common myths and straightforward truths
• Patient stories and the human side
• Practical checklist for someone considering peptides or GLP‑1s
• Resources
• FAQ
• Final practical notes from our clinical experience
• Where to learn more
• Closing practical tip

Why this conversation matters

We are living through a moment when new metabolic and regenerative tools are more accessible than ever. GLP-1 medications, peptides, NAD, and even exosome therapies have moved from niche clinical research into popular discussion. That is exciting. It is also messy. Our goal here is practical clarity: to unpack how these tools work, what risks matter most, when they help women, and how to navigate safety, dosing, and the bigger lifestyle context that makes any of this effective.

Guest snapshot

Dr. Thais Aliabadi and Mary Alice Haney talk with Dr. Tyna Moore, a naturopathic physician and chiropractor who’s spent decades in regenerative medicine and metabolic health. She blends clinical experience with a practical, integrative approach. Over the course of this interview, she shares how she evaluates peptides, why gut function is foundational to hormone optimization, how she approaches GLP‑1 microdosing, and what she watches for in long-term care.

Tell us about how you got into regenerative medicine and peptides — what shaped your approach?

We come at medicine the same way Dr. Moore does: the body is an integrated system, and symptoms rarely sit in isolation. Her early experience as a chronically ill child led to training in both chiropractic and naturopathic medicine, and that combined lens is why she gravitated toward regenerative medicine and peptides. She emphasizes listening to the patient, treating systemic contributors, and combining targeted tools with foundational lifestyle work.

Peptides 101

What exactly are peptides, and why do they matter?

Peptides are short chains of amino acids bound together by peptide bonds. Think of them as signaling molecules — small strings of amino acids that tell tissues to repair, regenerate, or dampen inflammation. Some peptides survive the digestive tract and can be taken orally; others require injection. The clinical uses span gut healing, tissue repair, inflammation control, immune modulation, and indirect stimulation of growth hormone.

How do you decide which peptides to use for a patient?

We do not use peptides as standalone magic bullets. They are tools that work best when the underlying body is optimized: adequate muscle mass, solid nutrition, good sleep, and hydration. Dr. Moore prefers starting with conservative approaches — oral options when available — and tailoring the choice to the clinical target. For gut healing, she may start with oral BPC‑157. For musculoskeletal repair, she considers TB500 in combination. For body composition or visceral fat, she looks at analogs like tesamorelin, sermorelin, or epithalon when appropriate and when regulated options are available.

Safe, practical peptide picks

Which peptides are approachable, and why do you favor oral forms?

Oral peptides carry a practical safety advantage: they are easier to stop, and less likely to introduce complications tied to injections. Three commonly discussed oral peptides are:

• BPC-157 — a regenerative “Wolverine” peptide that supports gut lining repair and helps with soft-tissue injuries. It’s short-acting and typically dosed daily when used.
• TB500 — often paired with BPC‑157 for regenerative and anti-inflammatory effects. Mechanisms differ, and they can be synergistic.
• KPV — an anti-inflammatory peptide available in supplement forms. Clinically, it is considered among the least concerning for long-term use.

For each, we favor low starting doses, short cycles (often 10–14 days for an initial trial), and careful symptom monitoring. That conservative approach reduces the risk of adverse effects such as swelling or stiffness that can emerge with higher or prolonged dosing.

How long should someone stay on a peptide?

We prefer cycles rather than indefinite use. Many of these peptides are pro-growth in nature, and long-term safety data in humans is limited. Even when a peptide seems beneficial, cycling allows the body to respond and minimizes potential risks. A typical strategy is a short trial, evaluate response, then repeat cycles as clinically indicated while addressing lifestyle and underlying drivers.

Regulatory and safety landscape

There’s a lot of gray market activity. What should people know?

The landscape is the wild west. Several peptides used in compounded forms were pulled from compounding lists in late 2023, and many remain available only through research-grade labs. These suppliers sell “research peptides” to clinics, and some clinicians reconstitute and label these products before dispensing them. That raises legitimate concerns about purity, provenance, and the presence of undisclosed agents — for example, GLP‑1 analogs added into mixtures without patients’ knowledge. Our position: treat any peptide source with scrutiny. Ask for certificates of analysis, confirm the pharmacy or lab source, and favor clinicians who share transparent sourcing and dosing rationales.

What side effects have you seen with peptides?

Adverse effects vary by molecule, dose, and patient sensitivity. We’ve seen external swelling, internal fluid shifts, headaches, stiffness, and, in rare cases, isolation of pro-growth signaling that could theoretically interact with cancer biology. Because of these risks, informed consent is critical. If a treatment is pro-growth, that should be part of the conversation.

NAD, exosomes, and their place

Is NAD a peptide, and what do you use it for?

NAD is a coenzyme, not a peptide. It supports mitochondrial function and the biochemical processes that produce ATP — the body’s energy currency. There are IV NAD protocols and subcutaneous (SC) formulations. Results are mixed across studies and individuals. We prefer oral or SC routes rather than IV drips because IVs can be unpredictable in the clinic and expensive. NAD can help energy and recovery in some patients, but it is not universally transformative.

What about exosomes?

Exosomes are cell-derived vesicles that carry signaling cargo. Early in regenerative medicine, they seemed promising and were used in many ways: intravenous, intra-articular, intravaginal, and intralesional. Regulatory scrutiny has intensified, and the FDA has stepped in to limit many uses. Exosomes are intensely pro-growth and can reduce inflammation quickly, but that same pro-growth quality makes them a potential double-edged sword in oncology or in cases with unknown malignancy. We avoid exosomes in routine practice now unless there is a tightly justified, risk‑tolerant scenario and clear oversight.

GLP‑1 medications and microdosing

Explain microdosing GLP‑1 — what is it and why would we consider it?

Microdosing means using well-below-standard starting doses of a GLP‑1 agonist to gain metabolic and neurologic benefits while minimizing side effects. Instead of beginning at the conventional 0.25 mg weekly or a full pen dose, microdosing might start at a fraction — a fifth to a tenth — and slowly increase. The clinical thinking: for lean or sensitive patients, we often do not want weight suppression; we may want to calm inflammation, quiet obsessive eating behaviors, ease autoimmune flares, or reduce anxiety-driven cravings. In those cases, a tiny “blip” of GLP‑1 can be enough to reset pathways without triggering heavy nausea or profound weight loss.

Who is an ideal candidate for GLP‑1 microdosing?

Microdosing is most useful for patients who are metabolically compromised but not necessarily obese, for those with inflammatory or autoimmune issues, and for individuals who are highly sensitive to medications. Examples include people with PCOS, Crohn’s disease, certain forms of depression or anxiety tied to metabolic signaling, and patients with persistent inflammation where weight loss isn’t the primary goal.

How do you actually dose a microdose protocol?

There is no single standard. We define microdosing as any dose below the lowest commercially available starting dose. Practically, that means:

• Start extremely low — sometimes at one-tenth or one-fifth of the usual initial dose.
• Monitor symptoms closely for 3–7 days after each administration. If nothing changes, increment slowly.
• Adjust frequency — some patients dose once weekly, others twice weekly; some benefit from twice-monthly dosing depending on the product.

Because individual responses vary, the clinician’s experience and the patient’s symptom profile guide titration. And importantly, if unintended weight loss occurs in a lean patient, we stop or lower the dose.

What are the biggest safety concerns with GLP‑1 use?

Two common problems stand out. First, patients getting higher-than-intended doses — often due to mislabeling or misunderstanding — can experience severe nausea, vomiting, dehydration, and require urgent care. Second, long-term outcomes are still being studied. We are optimistic about cardiovascular and neurologic benefits, but we must also monitor nutrient status, muscle mass, and bone health. When GLP‑1s suppress appetite, the risk of unintended muscle loss is real unless resistance training and adequate protein intake are prioritized.

Practical care pathways

Where do peptides, GLP‑1s, and lifestyle fit together?

These tools are part of a broader toolkit. We rarely rely on any single intervention. Our clinical flow often looks like this:

1. Baseline optimization: hydration, protein intake, sleep, circadian exposure to light, movement, and stress reduction.
2. Gut evaluation and repair: address dysbiosis, leaky gut, and digestive support.
3. Targeted short-term interventions: peptides, low-dose GLP‑1s, or hormone support to quell inflammation and stabilize the patient.
4. Gradual tapering or cycling: reduce reliance on interventions as the body heals and incorporate long-term maintenance strategies such as strength training and tailored nutrition.

We emphasize that lifestyle work often reduces the total medication burden and improves long-term outcomes.

Gut health as the foundation

Why do you insist on fixing the gut first?

Gut function influences hormone metabolism, immune signaling, inflammation, cravings, and even mood. If bowel transit and microbiome balance are poor, hormones recirculate improperly, metabolic inflammation increases, and many interventions fail to stick. Dr. Moore wants patients reliably pooping daily before she introduces long-term hormonal or metabolic agents. That may sound strict, but it is practical: poor gut clearance impairs estrogen metabolism and can worsen symptoms even when hormones are replaced.

How do you evaluate and treat a dysfunctional gut?

We are symptom-led. Tests like GI-MAP or comprehensive stool panels can reveal useful information, but negative tests do not rule out significant clinical dysfunction. Key steps include:

• Hydration and fiber adjustments to improve stool form.
• Dietary optimization to reduce inflammatory triggers and support microbial diversity.
• Targeted antimicrobials or herbal decontamination when clinical patterns suggest dysbiosis.
• Supportive peptides such as oral BPC‑157 or KPV to repair mucosal integrity.
• Addressing pelvic inflammatory drivers like endometriosis when gut symptoms are refractory.

For many patients, killing back a disruptive overgrowth and then restoring diversity through diet and targeted pre- and post-biotic strategies is the fastest path to consistent stool habits and symptom relief.

Hormone replacement therapy (HRT) for midlife women

How do you approach HRT for perimenopausal and menopausal women?

We treat HRT as highly individualized care. Before prescribing, we want lifestyle and gut processes stabilized. Our typical sequence is:

1. Address thyroid and adrenal function — these systems drive energy and foundational metabolic responses.
2. Start with micronized progesterone when sleep, anxiety, or mood symptoms predominate. Progesterone is often sedating, which is helpful for insomnia, but may not be tolerated by everyone.
3. If hot flashes and vasomotor symptoms are primary, we consider transdermal estrogen patches.
4. Testosterone use is symptom-driven — primarily low libido or diminished sexual function in women without contraindications.

We do not prescribe a one-size-fits-all triple hormone regimen. We start with the dominant symptom, monitor response, and add therapies in a staged fashion, always weighing metabolic and oncologic risks.

Exercise, resistance training, and practical tools

What type of exercise is most important for women in midlife?

Strength training is essential. It preserves muscle mass, supports metabolic health, stabilizes glucose, and protects bone density. Cardio and protein matter, but if we had to prioritize, lifting weights changes physiology in ways that resistance training uniquely supports — especially when someone is using appetite-suppressing medications or is at risk for sarcopenia.

What about weighted vests — do you recommend them?

Use depends on context. When used alongside a structured strength program, a weighted vest can add progressive overload for functional movements. However, they should complement, not replace, a resistance training program. Proper form and progressive programming remain the priority.

Supplements and small wins

What one supplement do you recommend for most women?

Magnesium. We favor forms like magnesium threonate for its ability to cross the blood-brain barrier in situations where sleep, anxiety, and CNS recovery are key targets. Magnesium helps with sleep, muscle relaxation, and can blunt overactive sympathetic tone. As always, choose the form to match the symptom: glycinate for sleep and tolerance; citrate if constipation is an issue.

Finding a clinician: what to look for

Most people can’t see experts in major metro areas. What criteria should they use when choosing a clinician for peptides, GLP‑1s, or HRT?

We recommend a mix of clinician competence and patient responsibility. Look for practitioners who:

• Demonstrate transparency about sources, dosing, and monitoring.
• Provide a clear treatment plan with short-term and long-term goals.
• Discuss lifestyle interventions first and frame medications as adjuncts.
• Offer stepwise titration and informed consent that includes potential pro-growth risks.
• Are willing to collaborate with you and other providers, and to provide clear lab and clinical follow-up.

If your care comes through a telemedicine company, be aware that cookie-cutter algorithms are common. They can be useful, but you are responsible for researching and asking questions. If they prescribe a high dose and call it “microdosing,” that is a red flag.

Common myths and straightforward truths

Do GLP‑1 medications make everyone healthier beyond weight loss?

The data on cardiovascular and neurologic benefits are promising, but we must be cautious. Benefits in trials are often mediated by metabolic improvements that correlate with weight loss and improved glycemic control. For lean or sensitive patients, the goal is often anti-inflammatory and neuromodulatory effects rather than weight reduction. We need more targeted studies on low-dose and microdose effects, but the clinical signals are encouraging.

Are exosomes and peptides safe for people with cancer?

Because exosomes and many peptides are pro-growth, they can be risky in active cancer or where malignancy is suspected. In rare, carefully controlled situations — when a patient is facing otherwise life-threatening inflammatory disease — the clinician and patient may decide the risk is worth it. Those are individualized, high-stakes conversations that require full disclosure, multidisciplinary collaboration, and explicit consent.

Patient stories and the human side

Clinical practice is full of examples that illustrate both the promise and the complexity of these tools. We see people who regained quality of life after targeted use of GLP‑1s for lymphedema or regained control of severe inflammation after careful regenerative work. We also see cases where overenthusiastic dosing, opaque compounding, or lack of lifestyle support created avoidable complications. Those real outcomes drive our conservative, measured approach.

Practical checklist for someone considering peptides or GLP‑1s

1. Document your baseline: weight, strength levels, sleep, bowel habits, mood, and medication history.
2. Fix the fundamentals: hydration, protein intake, sleep schedule, daily movement, and stress management.
3. Evaluate gut function and correct constipation or dysbiosis before starting long-term hormonal therapy.
4. Insist on transparency about sourcing and lab testing for any injectable you receive.
5. Choose a clinician who will titrate slowly, monitor labs and symptoms, and plan cycles rather than indefinite use.
6. Prioritize strength training to protect muscle while pursuing metabolic or weight adjustments.

Resources

Clinicians and patients should educate themselves using reputable clinical resources and choose providers that prioritize informed consent and individualized care. Consider training materials, guideline documents, and peer-reviewed literature when evaluating treatment options.

FAQs

What is GLP‑1 microdosing, and how is it different from standard dosing?

Microdosing starts at doses below the lowest commercially available starting dose and is titrated slowly to achieve neuromodulatory and metabolic effects without the full appetite suppression or side effects of standard dosing. It is individualized, symptom-driven, and often used for inflammation, autoimmune conditions, or psychiatric symptoms rather than weight loss.

Are oral peptides like BPC‑157 effective compared to injectables?

Many oral peptides are clinically useful and carry safety advantages because they are easier to stop and less invasive. BPC‑157 and TB500 are popular oral options for gut and soft tissue healing. Efficacy varies by person, and some injectable formulations were previously used for specific indications; availability has shifted due to regulatory changes.

How do I know if my peptide or GLP‑1 product is legitimate?

Ask the prescribing clinician for the pharmacy or lab certificate of analysis. Verify the compounding pharmacy’s credentials. Favor pharmaceutical-grade products when available. Avoid accepting proprietary mixes without clear ingredient lists. Transparency from the clinician about sourcing is essential.

Should every woman over 40 be on HRT?

No. HRT is individualized. We assess symptoms, metabolic status, and risks. Many women benefit from HRT, and some can stay on therapy long-term under monitoring. The treatment plan depends on clinical goals: sleep/anxiety, vasomotor symptoms, libido, bone health, and more.

What is the single most impactful lifestyle habit for hormone and metabolic health?

Strength training. It preserves muscle, supports metabolic flexibility, stabilizes blood sugar, protects bone density, and helps maintain function as hormones change. Consistent resistance work paired with adequate protein intake is central to preserving the gains made with medications.

Final practical notes from our clinical experience

We believe in empowering patients through education and careful stewardship of emerging tools. GLP‑1s, peptides, NAD, and regenerative techniques can be transformative when used thoughtfully. Yet none of them replace the fundamentals: sleep, hydration, nutrition, movement, and gut health. Our clinical mantra is cautious curiosity: we are curious enough to try new tools, but cautious enough to prioritize safety, transparency, and measurable goals.

If you are considering any of these therapies, come prepared: bring a clear symptom list, recent labs, a record of current medications and supplements, and a plan to work on the lifestyle basics in parallel. Choose clinicians who will titrate slowly, communicate openly, and build a plan that’s as committed to de-prescribing as it is to prescribing.

Where to learn more

For clinicians: seek continuing education on metabolic medicine, peptide pharmacology, and gut‑brain interactions. For patients: prioritize clinicians who explain sourcing, dosing, risks, and long-term strategies. Ask for follow-up labs and a concrete plan for lifestyle integration.

Closing practical tip

When you use a targeted therapy to quiet the acute fire — whether a peptide, a microdose of GLP‑1, or a short hormone course — pair it with a plan that will allow you to step down. Our best outcomes are those where interventions are scaffolding, not crutches. That way, the body regains resilience, and the tools become the accelerator, not the only engine.

This article was created from the video What Women Need To Know About GLP-1 Microdosing & Hormonal Health ft. Dr. Tyna Moore | SHE MD for Dr. Thais Aliabadi’s website.